Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
Al-Saadi: There were concerns that Lahham would be placed under administrative detention.
Al-Saadi: The Israeli occupation authorities could not prove any allegations leveled against Nasser Lahham.
Lawyer Oussama al-Saadi: The oppressive Israeli measures of delaying Lahham's release had vengeful motives.
Nasser Lahham's lawyer said the journalist was released without any conditions or restrictions, adding that the conditions in which he was kept were terrible.
The Israeli occupation authorities release Al Mayadeen Palestine bureau chief Nasser al-Lahham.
Local Syrian sources: An Israeli airstrike targeted a tank and artillery battalion in the city of Izraa in the Daraa countryside
Al Mayadeen's correspondent in eastern Lebanon: 12 martyrs and 5 wounded in Israeli raids targeting the outskirts of Wadi Fa'ra in the northern Bekaa Valley
Local Syrian sources: More than 10 Israeli raids targeted Sweida, with information about more than five casualties from the Internal Security Forces
Local Syrian sources: Initial reports indicate that approximately 15 people were killed or wounded at the al-Radwan family's guest house in Sweida following a direct exchange of gunfire
Israeli media, citing Israeli political sources, reported that the Shas movement is expected to withdraw from the government within less than 24 hours

FDA approves first postpartum depression pill in the US

  • By Al Mayadeen English
  • Source: News websites
  • 6 Aug 2023 22:14
3 Min Read

The FDA stated on Friday that the medication, to be offered under the trade name Zurzuvae, has been authorized as a once-daily tablet to be taken for 14 days.

  • x
  • FDA approves first postpartum depression pill in the US
    Postpartum depression affects 1 in 7 new mothers after childbirth. (AP)

Zuranolone has been approved by the US Food and Drug Administration to treat postpartum depression, the first FDA-approved oral pill in the US for the condition.

Postpartum depression is a serious mental condition that develops in nearly 1 in 7 new mothers after childbirth.

The FDA stated on Friday that the medication, to be offered under the trade name Zurzuvae, has been authorized as a once-daily tablet to be taken for 14 days.

According to Dr. Tiffany R. Farchione, director of the Division of Psychiatry in the FDA’s Center for Drug Evaluation and Research program, access to the drug will be beneficial for many women "coping with extreme, and sometimes life-threatening, feelings.” 

Read more: Medical experts say depression to become largest global health crisis

Suicidal thoughts may occur in women suffering from severe postpartum depression, and maternal suicide accounts for around 20% of all postpartum fatalities. It is estimated that over 400,000 infants are delivered to depressed moms in the United States each year. According to the National Institute of Mental Health, postpartum depression can persist for months or even years if not treated.

Related News

Hezbollah condemns Israeli Bekaa massacre, urges action from Lebanon

Lavrov seeks clarity on Trump's ceasefire or secondary tariffs threat

Moving the bar forward

Dr. Samantha Meltzer-Brody, director of the Center for Women’s Mood Disorders at the University of North Carolina at Chapel Hill called the approval "a very important step forward," adding that it would be the first rapidly acting antidepressant.

The postpartum period, she continued, was a critical time, and Zuranolone was found to be effective in some trials within three days. 

Catherine Monk, professor and chief of the division of women’s mental health in Obstetrics & Gynecology at Columbia University Vagelos College of Physicians and Surgeons, also praised the approval and "Fast-acting" nature of the drug.

Monk did express concern, however, those with mild or moderate postpartum depression should not immediately resort to the drug, since the medication was tested on those with severe postpartum depression, and psychotherapy should be the first response.

Her view was also shared by Judite Blanc, assistant professor of psychiatry and behavioral sciences at the University of Miami Miller School of Medicine, who explained that Zuranolone “could be particularly beneficial for women who face barriers to accessing long-term treatments, such as low-income women or those with limited healthcare access. However, from a scientific, social, and ethical standpoint, this clinical trial is not the panacea to tackle the maternal health crisis in the U.S. and globally."

She highlighted that “Medications shouldn’t be the first or only line of treatment for mental health conditions, particularly among women, children, and historically oppressed populations."

In addition, Blanc believes there should be more research done among breastfeeding mothers since the trials were mainly conducted on mothers who were not breastfeeding.

She warned that severe depression comes with suicidal ideation and most times a plan to do so. Monk encouraged mothers who feel they need help to seek it.

  • United States
  • FDA
  • Mental Health
  • depression
  • maternity

Most Read

Hezbollah SG reveals war details on Al Mayadeen for the first time

Hezbollah SG reveals war details on Al Mayadeen for the first time

  • Politics
  • 8 Jul 2025
Yemen Navy sinks ETERNITY C ship, shares footage of operation

Yemen Navy sinks ETERNITY C ship, shares footage of operation

  • Politics
  • 9 Jul 2025
This satellite image from Planet Labs PBC shows damage after an Iranian attack at the al Udeid Airbase outside of Doha, Qatar, June 25, 2025 (Planet Labs PBC via AP)

Satellite images show Iran attack damaged US comms dome in Qatari base

  • Politics
  • 11 Jul 2025
An Israeli soldier abandons an excavator during an ambush by al-Qassam Brigades. Arabic text reads "The moment the soldier fled", July, 10, 2025 (Al Qassam Military Media)

Israeli media rue al-Qassam footage, alarmed by fighters among troops

  • Politics
  • 11 Jul 2025

Coverage

All
The Ummah's Martyrs

Read Next

All
Syrian government forces deploy at the Mazraa village on the outskirts of city of Sweida, where clashes erupted between Bedouin clans and Druze factions, southern Syria, Monday, July 14, 2025 (AP)
Politics

Gulf-backed negotiations underway in Syria's Sweida to end clashes

UN: 798 Palestinians killed while trying to reach aid in Gaza
Palestine

UN: 798 Palestinians killed while trying to reach aid in Gaza

A damaged car is seen at a field that was hit in an Israeli airstrike in Nabi Sheet village, in Lebanon's eastern Bekaa Valley, Wednesday, August 21, 2024 (AP)
Politics

Hezbollah condemns Israeli Bekaa massacre, urges action from Lebanon

Palestinians walk next to the closed humanitarian aid distribution center of UNRWA, the UN agency helping Palestinian refugees in Jabaliya, Gaza Strip, on Tuesday, April 29, 2025 (AP)
Politics

Israeli regime cuts electricity, water supplies to UNRWA Gaza offices

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS